SUBSCRIBE
SUBSCRIBE

Asia

Pepsi’s New Fat Blocking Soda Unleashed on Japanese Consumers
November 19, 2012
 · 
1 min read
Could Fat-Blocking Pepsi Actually Work? Don’t Count On It
November 14, 2012
 · 
1 min read
Measuring Metabolism Can Predict Alzheimer’s Progress With 90 Percent Accuracy, Tel Aviv University Study
November 8, 2012
 · 
1 min read
New Portable Device Enables RNA Detection From Ultra-Small Sample in Only 20 Minutes, RIKEN Reveals
November 8, 2012
 · 
1 min read
Crohn’s Disease in Children May Start From Bacteria, University of New South Wales Study
November 1, 2012
 · 
1 min read
ATR Computational Neuroscience Laboratories Scientists in Sleep-Wake Tests Decode Dreams
October 31, 2012
 · 
1 min read
Sugary Drinks Linked to Higher Stroke Risk, American Journal of Clinical Nutrition Reveals
October 31, 2012
 · 
1 min read
Neuronix Ltd. Offers New Alzheimer’s Treatment
October 30, 2012
 · 
1 min read
The Implant in Your Bottom That Fights Heart Failure, University of Hong Kong Reveals
October 30, 2012
 · 
1 min read
Protein Regulation Linked to Intellectual Disability, University of Adelaide Study
October 26, 2012
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Formation Bio Licenses miR-124 Activator for Autoimmune Diseases from CTFH
January 30, 2026
 · 
3 min read
Press Releases
NEXTBIOMEDICAL Secures Health Canada Approval for Nexsphere-F™ in Musculoskeletal Pain Embolization
January 30, 2026
 · 
3 min read
Press Releases
Longeveron® Granted Japan Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells (MSCs)
January 29, 2026
 · 
7 min read
Press Releases
YD Bio Limited Enters into Binding Letter of Intent to Acquire Safe Save Medical Cell Sciences & Technology Co., Ltd., Bolstering Leadership in Advanced Immunocell Therapy
January 29, 2026
 · 
6 min read
Press Releases
SK bioscience Initiates International Phase 1/2 Clinical Trial of Universal Vaccine Candidate Targeting Sarbecovirus Family
January 29, 2026
 · 
5 min read
Press Releases
Ascletis Announces Positive Topline Results from Its Phase III Open-Label Study of Denifanstat (ASC40), a First-in-Class, Once-Daily Oral FASN Inhibitor for Acne
January 29, 2026
 · 
3 min read
Press Releases
Study Results of Novel TYK2 Inhibitor Soficitinib in Patients with AD Published by JAMA Dermatology
January 29, 2026
 · 
4 min read
Press Releases
Almirall Announces the Approval of Seysara® in China for the Treatment of Moderate-to-Severe Acne
January 29, 2026
 · 
8 min read
Press Releases
Takeda Reports Third-Quarter FY2025 Results: Updates Full Year Outlook to Reflect VYVANSE® Generics Impact, OPEX Discipline and FX Tailwind; Progressing Toward Three Transformative Launches Ahead
January 29, 2026
 · 
11 min read
Press Releases
Ivonescimab Included in FirstWord Pharma’s “The Drugs That Will Shape 2026"
January 29, 2026
 · 
4 min read
Press Releases
WuXi Biologics and Sinorda Biomedicine Enter Strategic Collaboration to Accelerate Development and Manufacturing of Innovative Bispecific Antibody
January 29, 2026
 · 
4 min read
Press Releases
QureBio Ltd. to Present at ASCO 2026 its Q-1802 Phase II Clinical Results
January 29, 2026
 · 
3 min read
Press Releases
CMUH-Ever Supreme Team Develops World-First Brain-Targeting Exosome Delivering Curcumin Across the Blood-Brain Barrier for Parkinson’s Disease
January 29, 2026
 · 
5 min read
Press Releases
Samsung Biologics receives EcoVadis Platinum, the highest sustainability rating
January 28, 2026
 · 
3 min read
Press Releases
Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse® G pTau 217 CSF Assay for Research Use Only
January 28, 2026
 · 
2 min read
Press Releases
Hanmi Secures Export Deal with Mexican Partner Sanfer for GLP-1 Obesity Drug and More
January 28, 2026
 · 
3 min read
Press Releases
Drug Farm Announces FDA Fast Track Designation for First-in-Class ALPK1 Inhibitor DF-003 for the Treatment of ROSAH Syndrome
January 28, 2026
 · 
3 min read
Press Releases
JCR Pharmaceuticals to Present at the 22nd Annual WORLDSymposium™ 2026
January 28, 2026
 · 
8 min read
Press Releases
Otsuka Announces FDA Acceptance and Priority Review of New Drug Application for Centanafadine for the Treatment of ADHD in Children, Adolescents, and Adults
January 28, 2026
 · 
5 min read
Press Releases
Asthma and Allergy Drug Development Is Failing Too Often--A Translational Reset Is Needed: HKEY-AIRx™1.0
January 28, 2026
 · 
4 min read
Load More